spacer
spacer

PDBsum entry 2pdp

Go to PDB code: 
protein ligands links
Oxidoreductase PDB id
2pdp

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
315 a.a. *
Ligands
NAP
393
Waters ×270
* Residue conservation analysis
PDB id:
2pdp
Name: Oxidoreductase
Title: Human aldose reductase mutant s302r complexed with idd 393.
Structure: Aldose reductase. Chain: a. Synonym: ar, aldehyde reductase. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: alr2. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
1.65Å     R-factor:   0.171     R-free:   0.241
Authors: H.Steuber,A.Heine,G.Klebe
Key ref:
H.Steuber et al. (2008). Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features. J Mol Biol, 379, 991-1016. PubMed id: 18495158 DOI: 10.1016/j.jmb.2008.03.063
Date:
01-Apr-07     Release date:   01-Apr-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P15121  (ALDR_HUMAN) -  Aldo-keto reductase family 1 member B1 from Homo sapiens
Seq:
Struc:
316 a.a.
315 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: E.C.1.1.1.21  - aldose reductase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. an alditol + NAD+ = an aldose + NADH + H+
2. an alditol + NADP+ = an aldose + NADPH + H+
alditol
+
NAD(+)
Bound ligand (Het Group name = NAP)
matches with 91.67% similarity
= aldose
+ NADH
+ H(+)
alditol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= aldose
+ NADPH
+ H(+)
   Enzyme class 2: E.C.1.1.1.300  - NADP-retinol dehydrogenase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: all-trans-retinol + NADP+ = all-trans-retinal + NADPH + H+
all-trans-retinol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= all-trans-retinal
+ NADPH
+ H(+)
   Enzyme class 3: E.C.1.1.1.372  - D/L-glyceraldehyde reductase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. glycerol + NADP+ = L-glyceraldehyde + NADPH + H+
2. glycerol + NADP+ = D-glyceraldehyde + NADPH + H+
glycerol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= L-glyceraldehyde
+ NADPH
+ H(+)
glycerol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= D-glyceraldehyde
+ NADPH
+ H(+)
   Enzyme class 4: E.C.1.1.1.54  - allyl-alcohol dehydrogenase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: allyl alcohol + NADP+ = acrolein + NADPH + H+
allyl alcohol
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= acrolein
+ NADPH
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/j.jmb.2008.03.063 J Mol Biol 379:991-1016 (2008)
PubMed id: 18495158  
 
 
Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
H.Steuber, A.Heine, A.Podjarny, G.Klebe.
 
  ABSTRACT  
 
Inhibition of human aldose reductase (ALR2) evolved as a promising therapeutic concept to prevent late complications of diabetes. As well as appropriate affinity and bioavailability, putative inhibitors should possess a high level of selectivity for ALR2 over the related aldehyde reductase (ALR1). We investigated the selectivity-determining features by gradually mapping the residues deviating between the binding pockets of ALR1 and ALR2 into the ALR2 binding pocket. The resulting mutational constructs of ALR2 (eight point mutations and one double mutant) were probed for their influence towards ligand selectivity by X-ray structure analysis of the corresponding complexes and isothermal titration calorimetry (ITC). The binding properties of these mutants were evaluated using a ligand set of zopolrestat, a related uracil derivative, IDD388, IDD393, sorbinil, fidarestat and tolrestat. Our study revealed induced-fit adaptations within the mutated binding site as an essential prerequisite for ligand accommodation related to the selectivity discrimination of the ligands. However, our study also highlights the limits of the present understanding of protein-ligand interactions. Interestingly, binding site mutations not involved in any direct interaction to the ligands in various cases show significant effects towards their binding thermodynamics. Furthermore, our results suggest the binding site residues deviating between ALR1 and ALR2 influence ligand affinity in a complex interplay, presumably involving changes of dynamic properties and differences of the solvation/desolvation balance upon ligand binding.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Comparative stereo representations of the related ALR1 (a) and ALR2 (b) inhibitor binding pockets.
Figure 2.
Fig. 2. Chemical formulae of the ALR2 inhibitors investigated in this study.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2008, 379, 991-1016) copyright 2008.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20213668 R.J.Falconer, A.Penkova, I.Jelesarov, and B.M.Collins (2010).
Survey of the year 2008: applications of isothermal titration calorimetry.
  J Mol Recognit, 23, 395-413.  
18949601 O.A.Barski, S.M.Tipparaju, and A.Bhatnagar (2008).
The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.
  Drug Metab Rev, 40, 553-624.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer